Oral Solid Dosage Forms (OSDF) Excipients Market

By Functionality;

Binders and Diluents

By Type of Excipients;

Natural Excipients and Synthetic Excipients

By Application;

Tablets/Capsules, Liquid Solution, Powders & Liquid/Solid Crystals, and Others

By End Use Industry;

Pharmaceuticals and Nutraceuticals

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn294893729 Published Date: August, 2025 Updated Date: September, 2025

Oral Solid Dosage Forms (OSDF) Excipients Market Overview

Oral Solid Dosage Forms (OSDF) Excipients Market (USD Million)

Oral Solid Dosage Forms (OSDF) Excipients Market was valued at USD 2203.26 million in the year 2024. The size of this market is expected to increase to USD 3100.20 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.0%.


Oral Solid Dosage Forms (OSDF) Excipients Market

*Market size in USD million

CAGR 5.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.0 %
Market Size (2024)USD 2203.26 Million
Market Size (2031)USD 3100.20 Million
Market ConcentrationMedium
Report Pages361
2203.26
2024
3100.20
2031

Major Players

  • BASF
  • Colorcon
  • Dow
  • FMC Health and Nutrition
  • Fuji Chemical Industry Co. Ltd.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Oral Solid Dosage Forms (OSDF) Excipients Market

Fragmented - Highly competitive market without dominant players


The Oral Solid Dosage Forms (OSDF) Excipients Market is advancing as tablets and capsules retain shares above 80% across prescriptions. In many OSDFs, total excipient load exceeds 75%, making flow aids, compression enhancers, and stabilizers indispensable. With broader use of patient‑friendly technologies, demand for high‑functionality excipients continues to rise.

Functional Backbones for Robust Tablets
Formulators deploy binders, diluents, and superdisintegrants to enable direct compression, now used in over 55% of new products. Toolkits based on MCC, lactose alternatives, and optimized cross‑linked polymers appear in more than 50% of DC builds, reinforcing mechanical strength, uniform content, and predictable disintegration.

Coatings & Release Engineering at Scale
Film‑coated tablets represent beyond 60% of launches, driving moisture control, smooth swallow, and consistent appearance. Modified‑release architectures constitute nearly 35% of OSDF innovations, where cellulosic matrices, methacrylate copolymers, and lipid systems enable extended, delayed, and targeted profiles that support better adherence.

User Experience & Acceptability Focus
Patient‑centric OSDFs prioritize palatability, mouthfeel, and fast dispersion. ODT and chewable concepts exceed 25% within user‑experience pipelines, while taste‑masked designs feature in over 40% of sensitive‑population candidates. Preference for sugar‑free, low‑irritant, and dye‑free excipients surpasses 30%, enhancing overall acceptability.

QbD Alignment & Reliable Throughput
More than 50% of programs apply QbD frameworks to define critical quality attributes and process ranges. Continuous manufacturing adoption has crossed 15% in solid dose settings, as direct compression reduces unit operations by about 30%. Tight‑spec pharma‑grade excipients are specified in above 60% of validations to secure reproducibility and release robustness.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Functionality
    2. Market Snapshot, By Type of Excipients
    3. Market Snapshot, By Application
    4. Market Snapshot, By End Use Industry
    5. Market Snapshot, By Region
  4. Oral Solid Dosage Forms (OSDF) Excipients Market Dynamics

    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing pharmaceutical R&D
        2. Growing demand for generic drugs
        3. Technological advancements in drug delivery
        4. Rising healthcare expenditure
      2. Restraints
        1. Stringent regulatory requirements
        2. High production costs
        3. Patent expirations limiting growth
        4. Complex supply chain logistics
      3. Opportunities
        1. Emerging markets
        2. Demand for innovative excipients
        3. Development of specialized formulations
        4. Increasing focus on patient compliance and convenience
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Oral Solid Dosage Forms (OSDF) Excipients Market, By Functionality, 2021 - 2031 (USD Million)

      1. Binders

      2. Diluents

    2. Oral Solid Dosage Forms (OSDF) Excipients Markett, By Type of Excipients, 2021 - 2031 (USD Million)

      1. Natural Excipients

      2. Synthetic Excipients

    3. Oral Solid Dosage Forms (OSDF) Excipients Market, By Application, 2021 - 2031 (USD Million)

      1. Tablets/Capsules
      2. Liquid Solution
      3. Powders and Liquid/Solid Crystals
      4. Others
    4. Oral Solid Dosage Forms (OSDF) Excipients Market, By End Use Industry, 2021 - 2031 (USD Million)

      1. Pharmaceuticals

      2. Nutraceuticals

    5. Oral Solid Dosage Forms (OSDF) Excipients Market, By Geography, 2021 - 2031 (USD Million)

      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. BASF
      2. Colorcon
      3. Dow
      4. FMC Health and Nutrition
      5. Fuji Chemical Industry Co. Ltd.
  7. Analyst Views
  8. Future Outlook of the Market